Idenix Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
04 July 2012 - 6:05AM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that
Idenix management will present a corporate overview at the 7th
Annual JMP Securities Healthcare Conference on July 12, 2012 at
9:30 a.m. ET at the Peninsula New York, New York City.
The live and archived webcast of the company presentation can be
accessed under "Events and Presentations" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived replay
will be available on the Idenix website for two weeks following the
conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of patients
with hepatitis C infection. For further information about Idenix,
please refer to http://www.idenix.com.
CONTACT: Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals News Articles